查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1933331

全球腦植入市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

Brain Implants Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 請詢問到貨日

價格

腦植入市場成長因素

由於神經系統疾病盛行率的上升、先進神經調控療法的廣泛應用以及醫療器材製造商在研發方面的大力投入，全球腦植入市場正經歷快速成長。腦植入物（也稱為神經植入物）是一種透過手術植入的裝置，它透過電刺激大腦特定區域來治療癲癇、帕金森氏症、阿茲海默症和精神分裂症等神經系統疾病。

2025年全球腦植入物市場價值23.6億美元。預計該市場將從2026年的26.2億美元成長到2034年的60.9億美元，在預測期（2026-2034年）內複合年增長率高達12.80%。北美在2025年佔全球市場主導地位，市佔率達45.53%，這得益於其先進的醫療基礎設施、高診斷率和有利的報銷政策。

新冠疫情的影響

新冠疫情對腦植入物市場產生了短期負面影響。醫院臨時關閉、擇期神經外科手術延遲以及患者就診量減少顯著減緩了市場成長。根據美國國家醫學圖書館（2021年11月）的數據顯示，疫情期間神經外科轉診量下降了33.6%，手術量下降了55.6%。

由於供應鏈中斷和手術延遲，主要公司的收入有所下降。例如，波士頓科學公司（Boston Scientific）的神經調控部門2020年的收入為7.61億美元，比2019年下降了12.8%。然而，隨著手術恢復和患者數量的回升，市場在2021年開始復甦。

市場趨勢

更重視柔性且先進的神經探針

腦植入物市場的主要趨勢之一是開發柔性探針，以減少傳統矽膠植入物造成的疤痕。研究機構正在探索絲素蛋白和藻酸鹽等可彎曲材料，以匹配腦組織的柔軟度。

2023年6月，格拉斯哥大學與我們合作，研究用於柔性腦探針的先進生物材料。此外，細胞療法與生物電子學的融合正成為一項突破性趨勢。 2023年3月，劍橋大學開發了一種神經植入物，可以幫助癱瘓患者恢復肢體功能。

市場成長驅動因素

神經系統疾病發生率上升

神經系統疾病發生率的上升是市場成長的主要驅動因素。根據世界衛生組織（2022年1月）的數據，全球有2400萬人患有精神分裂症；阿茲海默症協會（2023年3月）報告稱，美國有670萬65歲及以上的老年人患有阿茲海默症，預計到2060年，這一數字將達到1380萬。

提高公眾意識的宣傳活動、診斷率的提高以及醫療保健支出的成長，進一步推動了腦植入技術在全球的普及。

研發投入不斷增加

醫療器材製造商正大力投資研發，以開發創新型個人化腦植入技術。 2023年1月，Precision Neuroscience宣布將專注於開發“第七層皮層介面”，以幫助癱瘓患者，這凸顯了該市場由創新驅動的成長。

限制因子

儘管成長前景廣闊，但新興國家高昂的治療費用和有限的保險覆蓋範圍阻礙了市場滲透。例如，在土耳其，一台深部腦部刺激設備的平均成本為 28,000 至 29,000 美元，這限制了低收入地區的患者獲得治療的機會。此外，醫療基礎設施不發達和疾病認知度低也阻礙了市場滲透。

市場區隔分析

依產品劃分

在獲得多項 FDA 批准的推動下，深部腦部刺激療法在 2026 年佔了 65.60% 的市場佔有率。迷走神經刺激預計將實現顯著增長，而響應式神經刺激由於其個性化、即時治療能力，預計將以最快的複合年增長率增長。

依應用領域劃分

2024年，癲癇佔市場主導地位，而帕金森氏症在2026年佔33.94%的市場。由於患病率上升和新產品獲批，阿茲海默症預計將以更高的複合年增長率增長。

依最終使用者劃分

2026年，醫院以73.35%的市佔率領先，這主要是由於外科手術數量的增加和神經系統護理基礎設施的改善。

區域洞察

  • 北美：預計2025年市場規模將達10.7億美元。美國預計到2026年將達到10.4億美元。 2026年
  • 歐洲：由於健保報銷體系和教育舉措，預計成長強勁。
  • 亞太地區：由於人口老化和高性價比植入物，預計複合年增長率最高。
  • 世界其他地區（ROW）：由於神經系統疾病治療服務可近性的提高，預計將成長。

主要行業參與者

主要參與者包括美敦力、波士頓科學、雅培、Neuropace、LivaNova PLC 和 Areva NeuroTherapeutics。美敦力憑藉其強大的產品陣容和研發投入，在市場中處於領先地位。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 各國和地區主要神經系統疾病盛行率（2025 年）
  • 主要公司新產品發布
  • 主要產業趨勢：併購、業務合作
  • 腦植入技術進步
  • 主要地區的監管狀況
  • 新冠疫情的影響市場

第五章 全球腦植入市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品分類
    • 深部腦部刺激
    • 迷走神經刺激
    • 反應性神經刺激
  • 市場分析、洞察與預測：依應用分類
    • 癲癇
    • 帕金森氏症
    • 阿茲海默症
    • 精神分裂症
    • 其他
  • 市場分析、洞察與預測：依最終用戶分類
    • 醫院
    • 專科診所
    • 其他
  • 市場分析、洞察與預測：依地區分類
    • 北美美洲
    • 歐洲
    • 亞太地區
    • 世界其他地區 (ROW)

第六章 北美腦植入市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 美國
    • 加拿大

第七章 歐洲腦植入市場分析：洞察與預測 (2021-2034)

  • 依國家劃分
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 義大利
    • 斯堪的納維亞
    • 歐洲其他地區

第八章 亞太腦植入市場分析：洞察與預測（2021-2034）

  • 依國家劃分
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章：世界其他地區（ROW）腦植入市場分析：洞察與預測（2021-2034）

第10章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • Boston Scientific Corporation(U.S.)
    • Medtronic(Ireland)
    • Abbott(U.S.)
    • NeuroPace, Inc.(U.S.)
    • NDI Medical, LLC(U.S.)
    • ALEVA NEUROTHERAPEUTICS(Switzerland)
    • LivaNova PLC.(U.K.)
Product Code: FBI105021

Growth Factors of brain implants Market

The global brain implants market is witnessing rapid growth due to the rising prevalence of neurological disorders, increasing adoption of advanced neuromodulation therapies, and strong investments in research and development by medical device manufacturers. Brain implants, also known as neural implants, are surgically implanted devices that electrically stimulate specific regions of the brain to manage neurological conditions such as epilepsy, Parkinson's disease, Alzheimer's disease, and schizophrenia.

In 2025, the global brain implants market size was valued at USD 2.36 billion. The market is projected to grow from USD 2.62 billion in 2026 to USD 6.09 billion by 2034, exhibiting a strong CAGR of 12.80% during the forecast period (2026-2034). North America dominated the global market with a 45.53% share in 2025, supported by advanced healthcare infrastructure, high diagnosis rates, and favorable reimbursement policies.

COVID-19 Impact

The COVID-19 pandemic had a negative short-term impact on the brain implants market. Temporary hospital shutdowns, postponement of elective neurosurgeries, and reduced patient visits significantly slowed market growth. According to the National Library of Medicine (November 2021), neurosurgical referrals declined by 33.6%, while operations dropped by 55.6% during the pandemic.

Key players experienced revenue declines due to supply chain disruptions and delayed procedures. For instance, Boston Scientific's neuromodulation segment recorded revenues of USD 761.0 million in 2020, reflecting a 12.8% decline from 2019. However, the market began recovering in 2021 with the resumption of surgeries and improved patient footfall.

Market Trends

Rising Focus on Flexible and Advanced Neural Probes

One of the key trends in the brain implants market is the development of flexible probes to reduce scarring caused by traditional silicon-based implants. Research institutions are exploring bendable materials such as silk fibroin and alginate to better match brain tissue softness.

In June 2023, the University of Glasgow collaborated on research exploring advanced biological materials for flexible brain probes. Additionally, the integration of cell therapy with bioelectronics is emerging as a breakthrough trend. In March 2023, the University of Cambridge developed a neural implant capable of restoring limb function in paralyzed patients.

Market Growth Drivers

Rising Prevalence of Neurological Disorders

The growing incidence of neurological disorders is a primary driver of market growth. According to WHO (January 2022), 24 million people globally suffer from schizophrenia, while Alzheimer's Association (March 2023) reported 6.7 million Americans aged 65+ living with Alzheimer's disease, projected to reach 13.8 million by 2060.

Awareness campaigns, improving diagnosis rates, and rising healthcare expenditure are further driving the adoption of brain implants globally.

Increasing R&D Investments

Medical device manufacturers are heavily investing in R&D to develop innovative and personalized brain implant technologies. In January 2023, Precision Neuroscience focused on developing the Layer 7 Cortical Interface to assist patients with paralysis, highlighting the innovation-driven growth of the market.

Restraining Factors

Despite strong growth prospects, high treatment costs and limited reimbursement in emerging economies restrict market adoption. For example, the average cost of a deep brain stimulation device ranges between USD 28,000 and USD 29,000 in Turkey, limiting accessibility in low-income regions. Additionally, poor healthcare infrastructure and limited disease awareness further restrain market penetration.

Segmentation Analysis

By Product

Deep brain stimulation dominated the market with a 65.60% share in 2026, owing to multiple FDA approvals. Vagus nerve stimulation is expected to grow significantly, while responsive neurostimulation is projected to expand at the fastest CAGR due to personalized, real-time treatment capabilities.

By Application

Epilepsy dominated the market in 2024, while Parkinson's disease accounted for 33.94% share in 2026. Alzheimer's disease is expected to grow at a higher CAGR due to rising prevalence and new product approvals.

By End-user

Hospitals led the market with a 73.35% share in 2026, driven by higher surgical volumes and improved neurological care infrastructure.

Regional Insights

  • North America: Generated USD 1.07 billion in 2025; U.S. projected to reach USD 1.04 billion by 2026
  • Europe: Strong growth supported by reimbursement and awareness initiatives
  • Asia Pacific: Fastest CAGR due to aging population and cost-effective implants
  • Rest of the World: Growth driven by improved access to neurological care

Key Industry Players

Major players include Medtronic, Boston Scientific Corporation, Abbott, NeuroPace, LivaNova PLC, and ALEVA Neurotherapeutics. Medtronic leads the market with strong product offerings and R&D investments.

Conclusion

The global brain implants market is poised for robust growth, expanding from USD 2.36 billion in 2025 to USD 6.09 billion by 2034, driven by the rising prevalence of neurological disorders, increasing adoption of neuromodulation therapies, and strong R&D investments by key players. Although high treatment costs and limited reimbursement in emerging economies pose challenges, ongoing technological advancements, growing awareness, and expanding healthcare infrastructure are expected to support sustained market expansion over the forecast period.

Segmentation By Product

  • Deep Brain Stimulation
  • Vagus Nerve Stimulation
  • Responsive Neurostimulation

By Application

  • Epilepsy
  • Parkinson's Disease
  • Alzheimer's Disease
  • Schizophrenia
  • Others

By End-user

  • Hospitals
  • Specialty Clinics
  • Others

By Region

  • North America (By Product, By Application, By End-user, By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Application, By End-user, By Country/Sub-Region)
    • U.K.
    • Germany
    • France
    • Spain
    • Italy
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product, By Application, By End-user, By Country/Sub-Region)
    • Japan
    • China
    • India
    • Australia
    • Southeast Asia
    • Rest of the Asia Pacific
  • Rest of the World (By Product, By Application, By End-user)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Neurological Disorders, By Key Countries/Regions, 2025
  • 4.2. New Product Launches, By Key Players
  • 4.3. Key Industry Developments - Mergers, Acquisitions, and Partnerships
  • 4.4. Technological Advancements in Brain Implants
  • 4.5. Regulatory Scenario, Key Regions
  • 4.6. Impact of COVID-19 on the Market

5. Global Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Deep Brain Stimulation
    • 5.1.2. Vagus Nerve Stimulation
    • 5.1.3. Responsive Neurostimulation
  • 5.2. Market Analysis, Insights and Forecast - By Application
    • 5.2.1. Epilepsy
    • 5.2.2. Parkinson's Disease
    • 5.2.3. Alzheimer's Disease
    • 5.2.4. Schizophrenia
    • 5.2.5. Others
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Rest of the World

6. North America Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Deep Brain Stimulation
    • 6.1.2. Vagus Nerve Stimulation
    • 6.1.3. Responsive Neurostimulation
  • 6.2. Market Analysis, Insights and Forecast - By Application
    • 6.2.1. Epilepsy
    • 6.2.2. Parkinson's Disease
    • 6.2.3. Alzheimer's Disease
    • 6.2.4. Schizophrenia
    • 6.2.5. Others
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Deep Brain Stimulation
    • 7.1.2. Vagus Nerve Stimulation
    • 7.1.3. Responsive Neurostimulation
  • 7.2. Market Analysis, Insights and Forecast - By Application
    • 7.2.1. Epilepsy
    • 7.2.2. Parkinson's Disease
    • 7.2.3. Alzheimer's Disease
    • 7.2.4. Schizophrenia
    • 7.2.5. Others
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. U.K.
    • 7.4.2. Germany
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Deep Brain Stimulation
    • 8.1.2. Vagus Nerve Stimulation
    • 8.1.3. Responsive Neurostimulation
  • 8.2. Market Analysis, Insights and Forecast - By Application
    • 8.2.1. Epilepsy
    • 8.2.2. Parkinson's Disease
    • 8.2.3. Alzheimer's Disease
    • 8.2.4. Schizophrenia
    • 8.2.5. Others
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of the Asia Pacific

9. Rest of the World Brain Implants Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Deep Brain Stimulation
    • 9.1.2. Vagus Nerve Stimulation
    • 9.1.3. Responsive Neurostimulation
  • 9.2. Market Analysis, Insights and Forecast - By Application
    • 9.2.1. Epilepsy
    • 9.2.2. Parkinson's Disease
    • 9.2.3. Alzheimer's Disease
    • 9.2.4. Schizophrenia
    • 9.2.5. Others
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others

10. Competitive Analysis

  • 10.1. Global Market Share Analysis (2025)
  • 10.2. Company Profiles
    • 10.2.1. Boston Scientific Corporation (U.S.)
      • 10.2.1.1. Overview
      • 10.2.1.2. SWOT Analysis
      • 10.2.1.3. Recent Developments
      • 10.2.1.4. Strategies
      • 10.2.1.5. financials (Based on Availability)
    • 10.2.2. Medtronic (Ireland)
      • 10.2.2.1. Overview
      • 10.2.2.2. SWOT Analysis
      • 10.2.2.3. Recent Developments
      • 10.2.2.4. Strategies
      • 10.2.2.5. financials (Based on Availability)
    • 10.2.3. Abbott (U.S.)
      • 10.2.3.1. Overview
      • 10.2.3.2. SWOT Analysis
      • 10.2.3.3. Recent Developments
      • 10.2.3.4. Strategies
      • 10.2.3.5. financials (Based on Availability)
    • 10.2.4. NeuroPace, Inc. (U.S.)
      • 10.2.4.1. Overview
      • 10.2.4.2. SWOT Analysis
      • 10.2.4.3. Recent Developments
      • 10.2.4.4. Strategies
      • 10.2.4.5. financials (Based on Availability)
    • 10.2.5. NDI Medical, LLC (U.S.)
      • 10.2.5.1. Overview
      • 10.2.5.2. SWOT Analysis
      • 10.2.5.3. Recent Developments
      • 10.2.5.4. Strategies
      • 10.2.5.5. financials (Based on Availability)
    • 10.2.6. ALEVA NEUROTHERAPEUTICS (Switzerland)
      • 10.2.6.1. Overview
      • 10.2.6.2. SWOT Analysis
      • 10.2.6.3. Recent Developments
      • 10.2.6.4. Strategies
      • 10.2.6.5. financials (Based on Availability)
    • 10.2.7. LivaNova PLC. (U.K.)
      • 10.2.7.1. Overview
      • 10.2.7.2. SWOT Analysis
      • 10.2.7.3. Recent Developments
      • 10.2.7.4. Strategies
      • 10.2.7.5. financials (Based on Availability)

List of Tables

  • Table 1: Global Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 3: Global Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 4: Global Brain Implants Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 5: North America Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 6: North America Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 7: North America Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 8: North America Brain Implants Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 9: Europe Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 10: Europe Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 11: Europe Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 12: Europe Brain Implants Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 13: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 15: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 16: Asia Pacific Brain Implants Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 17: Rest of the World Brain Implants Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 18: Rest of the World Brain Implants Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 19: Rest of the World Brain Implants Market Revenue (USD billion) Forecast, by End-user, 2021-2034

List of Figures

  • Figure 1: Global Brain Implants Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Brain Implants Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Brain Implants Market Value Share (%), by Application, 2025 & 2034
  • Figure 4: Global Brain Implants Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Brain Implants Market Value (USD billion), by Region, 2025 & 2034
  • Figure 6: North America Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 7: North America Brain Implants Market Value Share (%), by Product, 2025
  • Figure 8: North America Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 9: North America Brain Implants Market Value Share (%), by Application, 2025
  • Figure 10: North America Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 12: North America Brain Implants Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Brain Implants Market Value Share (%), By Country, 2025
  • Figure 14: Europe Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 15: Europe Brain Implants Market Value Share (%), by Product, 2025
  • Figure 16: Europe Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 17: Europe Brain Implants Market Value Share (%), by Application, 2025
  • Figure 18: Europe Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Brain Implants Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Brain Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 23: Asia Pacific Brain Implants Market Value Share (%), by Product, 2025
  • Figure 24: Asia Pacific Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 25: Asia Pacific Brain Implants Market Value Share (%), by Application, 2025
  • Figure 26: Asia Pacific Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Brain Implants Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Brain Implants Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Rest of the World Brain Implants Market Value (USD billion), by Product, 2025 & 2034
  • Figure 31: Rest of the World Brain Implants Market Value Share (%), by Product, 2025
  • Figure 32: Rest of the World Brain Implants Market Value (USD billion), by Application, 2025 & 2034
  • Figure 33: Rest of the World Brain Implants Market Value Share (%), by Application, 2025
  • Figure 34: Rest of the World Brain Implants Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Rest of the World Brain Implants Market Value Share (%), by End-user, 2025
  • Figure 36: Global Brain Implants Market Share (%), By Company, 2025